Arcturus Share Price

Arcturus Share Price

NASDAQ: ARCT | Micro Cap | Healthcare
$7.86
-$0.12 (-1.5%) Last updated on 19 Nov, 2026 | 01:24 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Arcturus Stock Performance

Open
$8.09
Prev. Close
$7.98
Circuit Range
N/A
Day Range
$7.83 - $8.53
Year Range
$5.50 - $17.90
Volume
17,883
Average Traded
$8.08

Arcturus Share Price Today

As of 19 November 2026, Arcturus Therapeutics Holdings Inc.'s share price is $7.86. The stock opened at $8.09, compared to its previous close of $7.98. During today's trading session, Arcturus Therapeutics Holdings Inc.'s share price traded between $7.83 and $8.53, with an average price of $8.18. Over the past 52 weeks, the stock has recorded a high of $17.90 and a low of $5.50. In terms of performance, Arcturus Therapeutics Holdings Inc.'s share price has declined by 1.01% over the last six months and is up 16.10% on a year-on-year basis.

Arcturus Share Price Chart

Line chart of the Arcturus price trend over the selected period. The price fell overall, ranging from 7.83 to 8.56, ending at 7.86.
$7.83$8.53
L
Show Current Price
H

Arcturus Stock Fundamentals & Key Indicators

Market Cap
$215.25M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.03
Revenue (TTM)
$82.03B
Return On Equity (TTM)
-51.71%
Profit Margin
-80.19%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
74.52%

Arcturus Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$7.20$2.06$2.96$18.30
Net Profit-$29.08-$26.96-$23.79-$7.41
Net Profit Margin-403.89%-1308.74%-803.72%-40.49%
Income ChangeN/A7.29%11.76%68.85%

Arcturus Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$206.00$166.80$152.31$82.03
Net Profit$9.35-$29.73-$80.94-$65.78
Net Profit Margin4.54%-17.82%-53.14%-80.19%
Income ChangeN/A-417.97%-172.25%18.73%

Arcturus Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets29.738.0942.8147.05
Current Assets241.45305.98386.59403.33
Total Assets271.15344.07429.4450.39
Non Current Liabilities20.7837.668.953.09
Current Liabilities36.3865.4981.99126.98
Total Liabilities57.16103.09150.89180.08
Shareholders' Equity213.99240.98278.51270.31

Arcturus Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-74.27-59.75-18.131.99
Investing-0.23-0.65-2.9-7.73
Financing13.385.42-24.09-2.86

About Arcturus

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Arcturus Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$10.65
$7.86
-28.55%
Oct 2026
$13.47
$11.00
-19.88%
Sep 2026
$15.13
$13.73
-15.14%
Aug 2026
$5.86
$16.18
+181.15%
Jul 2026
$6.83
$5.75
-14.23%
Jun 2026
$7.71
$6.71
-15.49%
May 2026
$8.54
$7.94
-7.89%
Apr 2026
$7.99
$8.62
+11.51%
Mar 2026
$8.07
$7.73
-6.30%
Feb 2026
$7.37
$8.25
+10.15%
Jan 2026
$6.19
$7.49
+22.59%
Dec 2025
$6.47
$6.11
-9.75%

Arcturus Share Price FAQs